Skip to main content
Top
Published in: BMC Infectious Diseases 2/2021

Open Access 01-09-2021 | Sexually Transmitted Infection | Research

Recommendations for collection and integration of community-based testing and linkage to care data into national surveillance, monitoring and evaluation systems for HIV, viral hepatitis and sexually transmitted infections: results from the INTEGRATE Joint Action

Authors: Laura Fernàndez-López, Irena Klavs, Anna Conway, Tanja Kustec, Mojca Serdt, Sladjana Baros, Danica Valkovičová Staneková, Liis Lemsalu, Iwona Wawer, Piotr Wysocki, Jordi Casabona

Published in: BMC Infectious Diseases | Special Issue 2/2021

Login to get access

Abstract

Background

National testing strategy, including monitoring and evaluation, is critical in responding to HIV, sexually transmitted infections, and viral hepatitis. Community-based voluntary counselling and testing contributes to early HIV diagnoses among key populations. Countries providing community-based testing, should integrate some core data on testing and linkage to care in these services into national surveillance and monitoring and evaluation systems. This study aimed to support the integration of community-based voluntary counselling and testing data into respective national surveillance and M&E systems for those infections.

Methods

Preliminary consensus on indicators for the integration of community-based voluntary counselling and testing data into respective national surveillance and monitoring and evaluation systems was reached. Pilot studies were conducted in Estonia, Poland, Serbia, Slovakia, Slovenia and Spain. After pilot activities were implemented, the final consensus on indicators was reached. An analysis of the facilitators and barriers faced during pilot studies was conducted to inform the final recommendations for implementation.

Results

The minimum set of six indicators to be integrated into national surveillance and monitoring and evaluation systems were: number of tests, number of clients tested, reactivity rate for tests and clients, positivity (active infection) rates for tests and clients, linkage to care rates for clients with reactive and/or positive test result, proportion of all new diagnoses in a country with first reactive test result at community-based voluntary counselling and testing service. Seven additional indicators were identified. Each indicator should be disaggregated by key population, sex and age group. A list of 10 recommendations for the collection and integration of community-based voluntary counselling and testing data into national surveillance and monitoring and evaluation systems for HIV, sexually transmitted infections and viral hepatitis was identified.

Conclusions

Integration of some community-based voluntary counselling and testing monitoring and evaluation data into national surveillance and monitoring and evaluation systems in all pilot countries was achieved. The recommendations will support such integration in other European countries. European Centre for Prevention and Control of Diseases included questions from the minimum list of indicators into their Dublin Declaration questionnaire 2020 to contribute to evidence based community testing policies in European countries.
Literature
2.
go back to reference European Centre for Disease Prevention and Control. Public health guidance on HIV, hepatitis B and C testing in the EU/EEA: An integrated approach [Internet]. Stockholm; 2018 [cited 2021 May 25]. www.ecdc.europa.eu. European Centre for Disease Prevention and Control. Public health guidance on HIV, hepatitis B and C testing in the EU/EEA: An integrated approach [Internet]. Stockholm; 2018 [cited 2021 May 25]. www.​ecdc.​europa.​eu.
3.
go back to reference HIV-COBATEST Project. Cross-National Survey on the Implementation of CBVCT Programmes Quantitative Report. 2012. HIV-COBATEST Project. Cross-National Survey on the Implementation of CBVCT Programmes Quantitative Report. 2012.
10.
15.
go back to reference INTEGRATE Project. The integration of testing and linkage to care data from CBVCT services into national surveillance and monitoring and evaluation systems for HIV, STIs and hepatitis. Pilot report [Internet]. 2019. https://integrateja.eu/. INTEGRATE Project. The integration of testing and linkage to care data from CBVCT services into national surveillance and monitoring and evaluation systems for HIV, STIs and hepatitis. Pilot report [Internet]. 2019. https://​integrateja.​eu/​.
16.
go back to reference INTEGRATE project. Consensus recommendations for collection and integration of CBVCT testing and linkage to care data into national surveillance systems for HIV, viral hepatitis and STIs; 2020. [Internet]. [cited 2021 Feb 25]. https://integrateja.eu/. INTEGRATE project. Consensus recommendations for collection and integration of CBVCT testing and linkage to care data into national surveillance systems for HIV, viral hepatitis and STIs; 2020. [Internet]. [cited 2021 Feb 25]. https://​integrateja.​eu/​.
18.
go back to reference European Centre for Disease Prevention and Control. HIV testing Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report HIV testing [Internet]. Stockholm; 2019 [cited 2020 Jul 1]. www.ecdc.europa.eu. European Centre for Disease Prevention and Control. HIV testing Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report HIV testing [Internet]. Stockholm; 2019 [cited 2020 Jul 1]. www.​ecdc.​europa.​eu.
Metadata
Title
Recommendations for collection and integration of community-based testing and linkage to care data into national surveillance, monitoring and evaluation systems for HIV, viral hepatitis and sexually transmitted infections: results from the INTEGRATE Joint Action
Authors
Laura Fernàndez-López
Irena Klavs
Anna Conway
Tanja Kustec
Mojca Serdt
Sladjana Baros
Danica Valkovičová Staneková
Liis Lemsalu
Iwona Wawer
Piotr Wysocki
Jordi Casabona
Publication date
01-09-2021

Other articles of this Special Issue 2/2021

BMC Infectious Diseases 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine